Home » Profiles » Pharmaceutical Unit (automatic Plant Of Tablet And Capsule) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study

Pharmaceutical Unit (automatic Plant Of Tablet And Capsule) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study

The Indian pharmaceutical sector has come a long way, being almost non-existent before 1970 to a prominent provider of healthcare products, meeting almost 95 per cent of the country's pharmaceuticals needs. The Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously. Indian Pharma Industry is playing a key role in promoting and sustaining development in the vital field of medicines, besides this it boasts of quality producers and many units approved by regulatory authorities in USA and UK. International companies associated with this sector have stimulated, assisted and spearheaded this dynamic development in the past 53 years and helped to put India on the pharmaceutical map of the world. The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades. The leading 250 pharmaceutical companies control 70% of the market, with market leader holding nearly 7% of the market share. It is an extremely fragmented market with severe price competition and government price control. The pharmaceutical industry in India meets around 70% of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectables. There are about 250 large units and about 8000 Small Scale Units, which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units). These units produce the complete range of pharmaceutical formulations, i.e., medicines ready for consumption by patients and about 350 bulk drugs, i.e., chemicals having therapeutic value and used for production of pharmaceutical formulations. Technologically strong and totally self-reliant, the pharmaceutical industry in India has low costs of production, low R&D costs, innovative scientific manpower, strength of national laboratories and an increasing balance of trade. The Pharmaceutical Industry, with its rich scientific talents and research capabilities, supported by Intellectual Property Protection regime is well set to take on the international market. Market Survey The Indian pharmaceutical industry is the fourth largest in the world in terms of volume of output and thirteenth in domestic demand. However, the Indian industry, valued at USD 17 bn in represented just over 1% of the global pharmaceutical industry in value terms. The domestic market is estimated at Rs 680 bn. According to a study by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of USD 25 bn (Rs 1200 bn) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing. Incidentally, according to another report by Associated Chamber of Commerce (ASSOCHAM) in India, the market is estimated to grow to more modest level of USD 9.5 bn in 2010). India has the world's third largest active pharmaceutical ingredients (API) for the industry valued at a little less than USD 2 bn. Top 5 API producers account for approximately 6.5 %. The leading APIs are anti-infective, gastrointestinal, cardiovascular and respiratory drugs. However, India's pharmaceutical industry might witness some decline in the number of smaller companies that either leave the market or are acquired by larger Indian or foreign companies. Since 2000, a number of smaller Indian pharmaceutical companies have, in fact, been acquired by larger companies. These cases include, among the more notable ones, Wockhardt's acquisition of Merind and Tata Pharma; Ranbaxy's purchase of Crosland; Nicholas Piramal's acquisition of Roche etc. The Indian firms produce nearly 60,000 generic brands in 60 therapeutic categories and between 350 and 400 bulk drugs. India's drug market consists mainly of second and third generation drugs no longer subject to patent protection in the developed world. Although India is the world's leading producer of generic drugs, its annual per capita consumption of pharmaceuticals has been among the lowest placed approximately at USD 4.50 per person as compared to USD 820 in the United States and USD 13 in China. The bulk drugs segment continues to be the highest revenue generating segment for the Indian pharma industry. It accounts for production worth Rs 120 bn and contributes about 36% of the total pharma exports. India produces 400 bulk drugs through its 1,300 licensed bulk drug units that cater to most of the domestic bulk drug requirements. The key categories driving growth are the traditionally largest segment - anti-infective and gastro-intestinal, drugs, which expanded by 22% and 19% respectively. Fast sales growth is also visible in categories like respiratory (18%), cardiac (14%), neurology (20%) and anti-diabetic (19%). Anti-TB is the only category that has seen a decline in value and volume terms. The number of product launches exceeds 2,000 annually. Both MNC and Indian companies are implementing strategies which will help them to benefit from and cope with the developing patent regime. Global pharma companies are increasingly exploring low cost option to outsource research and manufacturing, because of emerging slow-down in patented drug sales and high cost of R&D. Indian pharmaceutical companies are in various stages of new drug discoveries. They have been scouting for global partners to help them in their goal. However, companies like Dr Reddy's Laboratories, Wockhardt’s, Glen mark Pharmaceuticals, Ranbaxy Laboratories, Orchid Chemicals and Lupin need financial and technical support from foreign pharmaceutical players to take their new drugs to the global market. Dr. Reddy's Laboratory (DRL) recently announced the beginning of Phase III clinical trials of its anti-diabetic drug Balagliatzone. Co-developed with Danish firm Rheoscience, the successful completion of the trial could give India its first intellectual property from the pharma sector. India has the highest number of (US Food and Drug Administration) USFDA approved manufacturing facilities outside the US and this puts India in good position to export to regulated markets. The major players in the country are: Aanjaneya Lifecare Ltd. Aashi Industries Ltd. Abbott India Ltd. Advik Laboratories Ltd. Aesculapius Remedies Ltd. Ajanta Pharma Ltd. Albert David Ltd. Alkem Laboratories Ltd. Alpa Laboratories Ltd. Ambalal Sarabhai Enterprises Ltd. Amee Cosmo Pharma Ltd. American Remedies Ltd. Amstrin Healthcare Ltd. Anan Drug & Chem Ltd. Andre Laboratories Ltd. Anglo-French Drugs & Inds. Ltd. Ankur Drugs & Pharma Ltd. Anmol Drugs & Pharmaceuticals Ltd. Anuh Pharma Ltd. Apex Laboratories Ltd. Apple Laboratories Ltd. Armour Chemicals Ltd. Arvind Remedies Ltd. Astrazeneca Pharma India Ltd. Astron Drugs & Inds. Ltd. Aurobindo Pharma Ltd. Aventis Pharma Ltd. B D H Industries Ltd. Bafna Pharmaceuticals Ltd. Bal Pharma Ltd. Basav Chem Ltd. Bassein Drugs Ltd. Beem Healthcare Ltd. Bengal Immunity Ltd. Beryl Drugs Ltd. Bharat Parenterals Ltd. Bharat Serums & Vaccines Ltd. Biddle Sawyer Ltd. Bio-Ethicals Pharma Ltd. Biocon Biopharmaceuticals Pvt. Ltd. Biocon Ltd. Biofil Chemicals & Pharmaceuticals Ltd. Biological E. Ltd. Blue Cross Laboratories Ltd. Boehringer Mannheim India Ltd. Brabourne Enterprises Ltd. Bravo Healthcare Ltd. Brawn Biotech Ltd. Burroughs Wellcome (India) Ltd. Cadila Healthcare Ltd. Cadila Laboratories Pvt. Ltd. Cadila Pharmaceuticals Ltd. Caplin Point Laboratories Ltd. Caryl Laboratories Ltd. Casil Industries Ltd. Celestial Biolabs Ltd. Centaur Pharmaceuticals Pvt. Ltd. Cepham Organics Ltd. Cepham Pharmaceuticals Ltd. Chemech Laboratories Ltd. Chemosyn Ltd. Ciba Ckd Biochem Ltd. Claris Lifesciences Ltd. Colinz Laboratories Ltd. Combat Drugs Ltd. Concept Pharmaceuticals Ltd. Concord Biotech Ltd. Concord Drugs Ltd. Coral Laboratories Ltd. Core Laboratories Ltd. Cosme Farma Laboratories Ltd. Cosme Pharma Ltd. Creative Health Care Pvt. Ltd. Croslands Research Laboratories Ltd. Croydon Chemical Works Ltd. Curewell (India) Ltd. Damania Pharma Ltd. Deepharma Laboratories Ltd. Deepharma Ltd. Dey'S Medical Stores Mfg. Ltd. Dishman Pharmaceuticals & Chemicals Ltd. Dolphin Laboratories Ltd. Dr. Reddy'S Laboratories Ltd. Druid Pharma Ltd. Dujohn Laboratories Ltd. Dumex Ltd. Eaco Labs Ltd. Earnest Healthcare Ltd. East India Pharmaceutical Works Ltd. Ebers Pharmaceuticals Ltd. Elder Health Care Ltd. Elder Pharmaceuticals Ltd. Elder Projects Ltd. Elvina Pharmaceuticals Ltd. Emaai Pharma Ltd. Emcure Pharmaceuticals Ltd. Endo Labs Ltd. Entod Pharmaceuticals Ltd. Esskay Pharmaceuticals Ltd. Ethnor Ltd. Eupharma Laboratories Ltd. Everest Organics Ltd. Evid & Co. Chemicals Ltd. F D C Ltd. Fine Drugs & Chemicals Ltd. Flamingo Pharmaceuticals Ltd. Fredun Pharmaceuticals Ltd. Fresenius Kabi Oncology Ltd. Fulford (India) Ltd. Geno Pharmaceuticals Ltd. Gentech Laboratories Ltd. Geoffrey Manners & Co. Ltd. German Remedies Ltd. Glaxosmithkline Pharmaceuticals Ltd. Glen mark Exports Ltd. Glen mark Generics Ltd. Glen mark Laboratories Ltd. Glen mark Pharmaceuticals Ltd. Global Remedies Ltd. Goa Antibiotics & Pharmaceuticals Ltd. Group Pharmaceuticals Ltd. Guardian Health Care Ltd. Gufic Biosciences Ltd. Gujarat Inject Ltd. Gujarat Terce Laboratories Ltd. Gujarat Themis Biosyn Ltd. H O D Laboratories Ltd. Hab Pharmaceuticals & Research Ltd. Haffkine Ajintha Pharmaceuticals Ltd. Hallmark Healthcare Ltd. Harleystreet Pharmaceuticals Ltd. Health Care Ltd. Hexone Pharmaceuticals Ltd. Hindustan Max-Gb Ltd. Hub Pharmaceuticals Pvt. Ltd. I D P L (Tamil Nadu) Ltd. Icon Biopharma & Healthcare Ltd. Icpa Health Products Ltd. Idma Laboratories Ltd. Ind-Swift Laboratories Ltd. Ind-Swift Ltd. India Infusion Ltd. Indian Drugs & Pharmaceuticals Ltd. Indoco Healthcare Ltd. Indoco Remedies Ltd. Indon Healthcare Ltd. Innotech Pharma Ltd. Intas Pharmaceuticals Ltd. Intercare Limited Intercare Ltd. International Drug Co. Ltd. Inventia Healthcare Pvt. Ltd. Inwinex Pharmaceuticals Ltd. Ipca Laboratories Ltd. Ivee Injectaa Ltd. J B Chemicals & Pharmaceuticals Ltd. J K Pharmachem Ltd. Jagsonpal Exports India Pvt. Ltd. Jagsonpal Pharmaceuticals Ltd. Jenburkt Pharmaceuticals Ltd. Jilichem Laboratories (India) Ltd. John Wyeth (India) Ltd. Johnson & Johnson Ltd. Kabra Drugs Ltd. Kappac Pharma Ltd. Karnataka Antibiotics & Pharmaceuticals Ltd. Kee Pharma Ltd. Kilitch Drugs (India) Ltd. Konkan Capsules Ltd. Krebs Biochemicals & Inds. Ltd. Labinduss Ltd. Lekar Healthcare Ltd. Lekar Pharma Ltd. Lincoln Pharmaceuticals Ltd. Liva Healthcare Ltd. Lordvin Labs Ltd. Lupin Laboratories Ltd. Lupin Ltd. Lyka B D R International Ltd. Lyka Labs Ltd. Lympha Laboratories Ltd. M J Pharmaceuticals Ltd. Macleods Pharmaceuticals Ltd. Maharashtra Antibiotics & Pharmaceuticals Ltd. Makers Laboratories Ltd. Maneesh Pharmaceuticals Ltd. Manipur State Drugs & Pharmaceuticals Ltd. Marck Biosciences Ltd. Mars Life Sciences Ltd. Martin & Harris Laboratories Ltd. Max India Ltd. Mayank & Lili Pharma Ltd. Mayo (India) Ltd. Mcneil & Argus Pharmaceuticals Ltd. Medicamen Biotech Ltd. Medispan Ltd. Medley Pharmaceuticals Ltd. Meghdoot Chemicals Ltd. Meher Pharma (India) Ltd. Merck Ltd. Mercury Laboratories Ltd. Mercury Phytochem Ltd. Merind Ltd. Mesco Pharmaceuticals Ltd. Metropolitan Overseas Ltd. Micro Labs Ltd. Monarch Laboratories Ltd. Morepen Laboratories Ltd. Mount Mettur Pharmaceuticals Ltd. N B Z Pharma Ltd. N R Jet Enterprises Ltd. Natco Pharma Ltd. Nem Organics Ltd. Neon Laboratories Ltd. Nestor Pharmaceuticals Ltd. Neulife Laboratories Ltd. Nirma Ltd. Nitya Laboratories Ltd. Novartis India Ltd. Novus Pharmaceuticals Ltd. Om Pharmaceuticals Ltd. Omega Biotech Ltd. Omega Laboratories Ltd. Onco Therapies Ltd. Opec Innovations Ltd. Orchid Chemicals & Pharmaceuticals Ltd. Organon (India) Ltd. Ozone Pharmaceuticals Ltd. P C I Chemicals & Pharmaceuticals Ltd. Paam Pharmaceuticals (Delhi) Ltd. Panacea Biotec Ltd. Parabolic Drugs Ltd. Paras Pharmaceuticals Ltd. Parke-Davis (India) Ltd. Penam Laboratories Ltd. Perk Pharmaceuticals Ltd. Pfimex Pharmaceuticals Ltd. Pfizer Ltd. Phaarmasia Ltd. Phar-East Laboratories Ltd. Pharmacia Healthcare Ltd. Pharmaids Pharmaceuticals Ltd. Pharmax Corporation Ltd. Pharmed Ltd. Phyto Specialities Pvt. Ltd. Plethico Pharmaceuticals Ltd. Procter & Gamble Hygiene & Health Care Ltd. Quality Pharmaceuticals Ltd. R P G Life Sciences Ltd. Rajasthan Drugs & Pharmaceuticals Ltd. Rajat Pharmachem Ltd. Ranbaxy Drugs Ltd. Ranbaxy Laboratories Ltd. Raptakos, Brett & Co. Ltd. Ravish Infusions Ltd. Reckitt Benckiser (India) Ltd. Rekvina Laboratories Ltd. Resonance Specialties Ltd. Rhone-Poulenc (India) Ltd. Rolex Pharmaceuticals Ltd. Rosemount Pharma India Ltd. Rubra Medicaments Ltd. Rupal Chemical Inds. Ltd. Rusan Pharma Ltd. S A M Biotech Ltd. Saket Projects Ltd. Sandoz (India) Ltd. [Amalgamated] Sanjeevanee Pharmaceuticals Ltd. Sanjivani Paranteral Ltd. Sanofi-Synthelabo (India) Ltd. Sarabhai Piramal Pharmaceuticals Pvt. Ltd. Sarala Pharmaceuticals Ltd. Sarthi Pharmaceuticals Ltd. Sarvodaya Labs Ltd. Schering-Plough (India) Pvt. Ltd. Senbo Industries Ltd. Shalina Laboratories Pvt. Ltd. Sharvani Pharmaceuticals Ltd. Shiv Herbal Research Laboratory Ltd. Sidmak Laboratories (India) Pvt. Ltd. Sigma Laboratories Ltd. Smith Stanistreet Pharmaceuticals Ltd. Smithkline Beecham Pharmaceuticals (India) Ltd. [Amalgamated] Solumiks Herbaceuticals Ltd. Sri Chakra Remedies Ltd. Sri Krishna Drugs Ltd. Sri Krishna Pharmaceuticals Ltd. Strides Arcolab Ltd. Sun Pharmaceutical Inds. Ltd. Surya Pharmaceutical Ltd. Sustime Pharma Ltd. Suyog Pharmaceuticals Pvt. Ltd. Swega Laboratories Ltd. Swet-Chem Antibiotics Ltd. Syncom Formulations (India) Ltd. Syncom Healthcare Ltd. T K Healthcare Ltd. Tablets (India) Ltd. Tamilnadu Dadha Pharmaceuticals Ltd. Targof Pure Drugs Ltd. Taulis Pharma Ltd. Teem Laboratories Ltd. Themis Medicare Ltd. Tonira Pharma Ltd. Torrent Pharmaceuticals Ltd. Toshvin Industries Ltd. Trans Medicare Ltd. Travel Co. In Pvt. Ltd. Troika Pharmaceuticals Ltd. Twilight Litaka Pharma Ltd. U S V Ltd. Uni-Sankyo Ltd. Uni-Ucb Ltd. Unibios Laboratories Ltd. Unichem Laboratories Ltd. Unicorn Pharmaceuticals (India) Ltd. Unimark Remedies Ltd. Unimed Investments Ltd. Unimed Technologies Ltd. Unique Pharmaceutical Laboratories Ltd. Universal Generics Ltd. Universal Pharmaceuticals Ltd. Unjha Formulations Ltd. Vellanova Pharmaceuticals Ltd. Venkat Pharma Ltd. Veronica Laboratories Ltd. Vista Pharmaceuticals Ltd. Vita Biopharma Pvt. Ltd. Vysali Pharmaceuticals Ltd. Wallace Pharmaceuticals Ltd. Wander Pvt. Ltd. Warren Pharmaceuticals Ltd. Welcure Drugs & Pharmaceuticals Ltd. White Way Products (Pharma) Ltd. Win-Medicare Pvt. Ltd. Wintac Ltd. Wockhardt’s Ltd. Wyeth Laboratories Ltd. Wyeth Ltd. Yogi Healthcare Ltd. Zenith Health Care Ltd. Zenotech Laboratories Ltd. Zillion Pharmachem Ltd. Zim Laboratories Ltd. Zuventus Healthcare Ltd. Zydus Animal Health Ltd. Zydus Pathline Ltd.
Plant capacity: 117 Lakhs Nos. /annumPlant & machinery: Rs. 125 Lakhs
Working capital: -T.C.I: Cost of Project: Rs. 1339 Lakhs
Return: 43.00%Break even: 54.00%
Email Us | Add to Inquiry Add to Inquiry Basket

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.


Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. Its various services are: Pre-feasibility study, New Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Preparation of Project Profiles and Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects and industry.

NPCS also publishes varies technology books, directory, databases, detailed project reports, market survey reports on various industries and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by Indian and overseas professionals including project engineers, information services bureau, consultants and consultancy firms as one of the input in their research.

^ Top

Products & Services


Contact Us

My Account


Payment Options

  • Credit Cards
  • Debit Cards
  • PayPal
  • Net Banking - (All Major Indian Banks)

We Process

  • Cards

Google Search